-
1.发明申请Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositions comprising them and their use in the treatment of obesity 失效CB1受体拮抗剂和西布曲明的组合，包含它们的药物组合物及其在治疗肥胖中的用途公开(公告)号：US20050032774A1
公开(公告)日：2005-02-10
申请号：US10941242
申请日：2004-09-15
IPC分类号： A61K31/135 , A61K31/397 , A61K31/137
CPC分类号： A61K31/135 , A61K31/137 , A61K31/353 , A61K31/397 , A61K31/445 , A61K31/454 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the combination of a CB1 receptor antagonist and of sibutramine, to the pharmaceutical compositions comprising them and to their use in the treatment of obesity.
摘要翻译： 本发明涉及CB1受体拮抗剂和西布曲明的组合，涉及包含它们的药物组合物及其在治疗肥胖症中的用途。
-
2.发明申请COMBINATION OF A CB1 RECEPTOR ANTAGONIST AND OF SIBUTRAMINE, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF OBESITY 审中-公开CB1受体拮抗剂和SIBUTRAMINE的组合，包含它们的药物组合物及其在治疗糖尿病中的应用公开(公告)号：US20060258709A1
公开(公告)日：2006-11-16
申请号：US11461468
申请日：2006-08-01
IPC分类号： A61K31/454 , A61K31/353 , A61K31/137
CPC分类号： A61K31/135 , A61K31/137 , A61K31/353 , A61K31/397 , A61K31/445 , A61K31/454 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the combination of a CB1 receptor antagonist and of sibutramine, to the pharmaceutical compositions comprising them and to their use in the treatment of obesity.
摘要翻译： 本发明涉及CB1受体拮抗剂和西布曲明的组合，涉及包含它们的药物组合物及其在治疗肥胖症中的用途。
-
公开(公告)号：US07037944B2
公开(公告)日：2006-05-02
申请号：US10941190
申请日：2004-09-15
IPC分类号： A61K31/135 , A61K31/397
CPC分类号： A61K31/135 , A61K31/137 , A61K31/353 , A61K31/397 , A61K31/445 , A61K31/454 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the combination of a CB1 receptor antagonist and of sibutramine, to the pharmaceutical compositions comprising them and to their use in the treatment of obesity.
-
公开(公告)号：US07148258B2
公开(公告)日：2006-12-12
申请号：US10941242
申请日：2004-09-15
IPC分类号： A61K31/135 , A61K31/397
CPC分类号： A61K31/135 , A61K31/137 , A61K31/353 , A61K31/397 , A61K31/445 , A61K31/454 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the combination of a CB1 receptor antagonist and of sibutramine, to the pharmaceutical compositions comprising them and to their use in the treatment of obesity.
-
5.发明申请COMBINATION OF A CB1 RECEPTOR ANTAGONIST AND OF SIBUTRAMINE, THE PHARMACEUTICAL COMPOSITIONS COMPRISING THEM AND THEIR USE IN THE TREATMENT OF OBESITY 审中-公开CB1受体拮抗剂和SIBUTRAMINE的组合，包含它们的药物组合物及其在治疗糖尿病中的应用公开(公告)号：US20080058381A1
公开(公告)日：2008-03-06
申请号：US11937121
申请日：2007-11-08
IPC分类号： A61K31/445 , A61K31/135 , A61P3/00
CPC分类号： A61K31/135 , A61K31/137 , A61K31/353 , A61K31/397 , A61K31/445 , A61K31/454 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the combination of a CB1 receptor antagonist and of sibutramine, to the pharmaceutical compositions comprising them and to their use in the treatment of obesity.
摘要翻译： 本发明涉及CB1受体拮抗剂和西布曲明的组合，涉及包含它们的药物组合物及其在治疗肥胖症中的用途。
-
6.发明申请Combination of a CB1 receptor antagonist and of sibutramine, the pharmaceutical compositons comprising them and their use in the treatment of obesity 失效CB1受体拮抗剂和西布曲明的组合，包含它们的药物组合物及其在治疗肥胖症中的应用公开(公告)号：US20050032773A1
公开(公告)日：2005-02-10
申请号：US10941190
申请日：2004-09-15
IPC分类号： A61K31/135 , A61K31/397 , A61K31/137
CPC分类号： A61K31/135 , A61K31/137 , A61K31/353 , A61K31/397 , A61K31/445 , A61K31/454 , A61K45/06 , A61K2300/00
摘要： The present invention relates to the combination of a CB1 receptor antagonist and of sibutramine, to the pharmaceutical compositions comprising them and to their use in the treatment of obesity.
摘要翻译： 本发明涉及CB1受体拮抗剂和西布曲明的组合，涉及包含它们的药物组合物及其在治疗肥胖症中的用途。
-
-
-
-
-
搜索结果
6 条记录 (耗时 0.011 秒)
